Carbetocin is a drug medication used to prevent excessive bleeding (postpartum hemorrhage) after giving birth, particularly following cesarean section. The drug is an analog of oxytocin and works similar to that of oxytocin. It is administered by injection in the vein or muscle. A single dose of this drug act as 16 hours intravenous oxytocin infusion regarding the increase in uterine tone.
MARKET SCOPE
The "Global Carbetocin Injection Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the carbetocin injection market with detailed market segmentation by type, end user, and geography. The report provides key statistics on the market status of the leading carbetocin injection market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on type, the global carbetocin injection market is segmented into original drug and generic drug.
- On the basis of end-users, the market is bifurcated into hospitals, clinics and other.
MARKET DYNAMICS
Drivers:
- Increasing incidences of postpartum hemorrhage and increasing birth rate drive the carbetocin injection market growth.
- Growing research & development activities and the introduction of technologically advanced products fuel market growth.
- Advanced facilities in hospital infrastructure in developing countries propel market growth.
Restraints:
- Repeated or overdosage of the drug causes various problems.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The carbetocin injection market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the carbetocin injection market in these regions.
IMPACT OF COVID-19 ON CARBETOCIN INJECTION MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. Due to the pandemic, the worldwide pharmaceutical market was affected. The worldwide lockdown, supply and production chain disruption, and business shutdown have impacted the market's growth. Non-essential surgeries were postponed, and only emergency procedures were allowed to be carried out. Hence, the above-mentioned factors affected the development of the carbetocin market in the pandemic period.
Have a question?
Akshay
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The carbetocin injection market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the carbetocin injection market in these regions.
IMPACT OF COVID-19 ON CARBETOCIN INJECTION MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. Due to the pandemic, the worldwide pharmaceutical market was affected. The worldwide lockdown, supply and production chain disruption, and business shutdown have impacted the market's growth. Non-essential surgeries were postponed, and only emergency procedures were allowed to be carried out. Hence, the above-mentioned factors affected the development of the carbetocin market in the pandemic period.
MARKET PLAYERS
The report covers key developments in the carbetocin injection market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from carbetocin injection market are anticipated to have lucrative growth opportunities in the future with the rising demand for carbetocin injection in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the carbetocin injection market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Ferring Pharmaceuticals
- Hybio Pharmaceutical
- Pfizer
- Beacon Pharmaceuticals Ltd.
- Chengdu Shengnuo Biotechnology
- Tibet Aim Pharm Inc (Aim Pharm)
- SGPharma
- Smokin Joe
- MDA INC.
- Taj Pharmaceuticals
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Carbetocin Injection Market - By Type
1.3.2 Carbetocin Injection Market - By End-user
1.3.3 Carbetocin Injection Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CARBETOCIN INJECTION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CARBETOCIN INJECTION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CARBETOCIN INJECTION MARKET - GLOBAL MARKET ANALYSIS
6.1. CARBETOCIN INJECTION - GLOBAL MARKET OVERVIEW
6.2. CARBETOCIN INJECTION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. CARBETOCIN INJECTION MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ORIGINAL DRUG
7.3.1. Overview
7.3.2. Original Drug Market Forecast and Analysis
7.4. GENERIC DRUG
7.4.1. Overview
7.4.2. Generic Drug Market Forecast and Analysis
8. CARBETOCIN INJECTION MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
8.1. OVERVIEW
8.2. END-USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis
9. CARBETOCIN INJECTION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Carbetocin Injection Market Overview
9.1.2 North America Carbetocin Injection Market Forecasts and Analysis
9.1.3 North America Carbetocin Injection Market Forecasts and Analysis - By Type
9.1.4 North America Carbetocin Injection Market Forecasts and Analysis - By End-user
9.1.5 North America Carbetocin Injection Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Carbetocin Injection Market
9.1.5.1.1 Canada Carbetocin Injection Market by Type
9.1.5.1.2 Canada Carbetocin Injection Market by End-user
9.1.5.2 Mexico Carbetocin Injection Market
9.1.5.2.1 Mexico Carbetocin Injection Market by Type
9.1.5.2.2 Mexico Carbetocin Injection Market by End-user
9.1.5.3 US Carbetocin Injection Market
9.1.5.3.1 US Carbetocin Injection Market by Type
9.1.5.3.2 US Carbetocin Injection Market by End-user
9.2. EUROPE
9.2.1 Europe Carbetocin Injection Market Overview
9.2.2 Europe Carbetocin Injection Market Forecasts and Analysis
9.2.3 Europe Carbetocin Injection Market Forecasts and Analysis - By Type
9.2.4 Europe Carbetocin Injection Market Forecasts and Analysis - By End-user
9.2.5 Europe Carbetocin Injection Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Carbetocin Injection Market
9.2.5.1.1 Germany Carbetocin Injection Market by Type
9.2.5.1.2 Germany Carbetocin Injection Market by End-user
9.2.5.2 France Carbetocin Injection Market
9.2.5.2.1 France Carbetocin Injection Market by Type
9.2.5.2.2 France Carbetocin Injection Market by End-user
9.2.5.3 Italy Carbetocin Injection Market
9.2.5.3.1 Italy Carbetocin Injection Market by Type
9.2.5.3.2 Italy Carbetocin Injection Market by End-user
9.2.5.4 Spain Carbetocin Injection Market
9.2.5.4.1 Spain Carbetocin Injection Market by Type
9.2.5.4.2 Spain Carbetocin Injection Market by End-user
9.2.5.5 United Kingdom Carbetocin Injection Market
9.2.5.5.1 United Kingdom Carbetocin Injection Market by Type
9.2.5.5.2 United Kingdom Carbetocin Injection Market by End-user
9.2.5.6 Rest of Europe Carbetocin Injection Market
9.2.5.6.1 Rest of Europe Carbetocin Injection Market by Type
9.2.5.6.2 Rest of Europe Carbetocin Injection Market by End-user
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Carbetocin Injection Market Overview
9.3.2 Asia-Pacific Carbetocin Injection Market Forecasts and Analysis
9.3.3 Asia-Pacific Carbetocin Injection Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Carbetocin Injection Market Forecasts and Analysis - By End-user
9.3.5 Asia-Pacific Carbetocin Injection Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Carbetocin Injection Market
9.3.5.1.1 Australia Carbetocin Injection Market by Type
9.3.5.1.2 Australia Carbetocin Injection Market by End-user
9.3.5.2 China Carbetocin Injection Market
9.3.5.2.1 China Carbetocin Injection Market by Type
9.3.5.2.2 China Carbetocin Injection Market by End-user
9.3.5.3 India Carbetocin Injection Market
9.3.5.3.1 India Carbetocin Injection Market by Type
9.3.5.3.2 India Carbetocin Injection Market by End-user
9.3.5.4 Japan Carbetocin Injection Market
9.3.5.4.1 Japan Carbetocin Injection Market by Type
9.3.5.4.2 Japan Carbetocin Injection Market by End-user
9.3.5.5 South Korea Carbetocin Injection Market
9.3.5.5.1 South Korea Carbetocin Injection Market by Type
9.3.5.5.2 South Korea Carbetocin Injection Market by End-user
9.3.5.6 Rest of Asia-Pacific Carbetocin Injection Market
9.3.5.6.1 Rest of Asia-Pacific Carbetocin Injection Market by Type
9.3.5.6.2 Rest of Asia-Pacific Carbetocin Injection Market by End-user
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Carbetocin Injection Market Overview
9.4.2 Middle East and Africa Carbetocin Injection Market Forecasts and Analysis
9.4.3 Middle East and Africa Carbetocin Injection Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Carbetocin Injection Market Forecasts and Analysis - By End-user
9.4.5 Middle East and Africa Carbetocin Injection Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Carbetocin Injection Market
9.4.5.1.1 South Africa Carbetocin Injection Market by Type
9.4.5.1.2 South Africa Carbetocin Injection Market by End-user
9.4.5.2 Saudi Arabia Carbetocin Injection Market
9.4.5.2.1 Saudi Arabia Carbetocin Injection Market by Type
9.4.5.2.2 Saudi Arabia Carbetocin Injection Market by End-user
9.4.5.3 U.A.E Carbetocin Injection Market
9.4.5.3.1 U.A.E Carbetocin Injection Market by Type
9.4.5.3.2 U.A.E Carbetocin Injection Market by End-user
9.4.5.4 Rest of Middle East and Africa Carbetocin Injection Market
9.4.5.4.1 Rest of Middle East and Africa Carbetocin Injection Market by Type
9.4.5.4.2 Rest of Middle East and Africa Carbetocin Injection Market by End-user
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Carbetocin Injection Market Overview
9.5.2 South and Central America Carbetocin Injection Market Forecasts and Analysis
9.5.3 South and Central America Carbetocin Injection Market Forecasts and Analysis - By Type
9.5.4 South and Central America Carbetocin Injection Market Forecasts and Analysis - By End-user
9.5.5 South and Central America Carbetocin Injection Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Carbetocin Injection Market
9.5.5.1.1 Brazil Carbetocin Injection Market by Type
9.5.5.1.2 Brazil Carbetocin Injection Market by End-user
9.5.5.2 Argentina Carbetocin Injection Market
9.5.5.2.1 Argentina Carbetocin Injection Market by Type
9.5.5.2.2 Argentina Carbetocin Injection Market by End-user
9.5.5.3 Rest of South and Central America Carbetocin Injection Market
9.5.5.3.1 Rest of South and Central America Carbetocin Injection Market by Type
9.5.5.3.2 Rest of South and Central America Carbetocin Injection Market by End-user
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. CARBETOCIN INJECTION MARKET, KEY COMPANY PROFILES
11.1. FERRING PHARMACEUTICALS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. HYBIO PHARMACEUTICAL
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. PFIZER
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BEACON PHARMACEUTICALS LTD.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CHENGDU SHENGNUO BIOTECHNOLOGY
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. TIBET AIM PHARM INC (AIM PHARM)
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SGPHARMA
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SMOKIN JOE
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MDA INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TAJ PHARMACEUTICALS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Ferring Pharmaceuticals
2. Hybio Pharmaceutical
3. Pfizer
4. Beacon Pharmaceuticals Ltd.
5. Chengdu Shengnuo Biotechnology
6. Tibet Aim Pharm Inc (Aim Pharm)
7. SGPharma
8. Smokin Joe
9. MDA INC.
10. Taj Pharmaceuticals
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Carbetocin Injection Market
Apr 2024
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Apr 2024
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Apr 2024
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Apr 2024
Drug Delivery Market
Forecast to 2028 - Global Analysis By Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)